143 related articles for article (PubMed ID: 27719639)
1. Hedgehog Signaling Pathway as Genetic and Epigenetic Target in Ovarian Tumors.
Levanat S; Sabol M; Musani V; Ozretic P; Trnski D
Curr Pharm Des; 2017; 23(1):73-94. PubMed ID: 27719639
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog signaling pathway as a therapeutic target for ovarian cancer.
Li H; Li J; Feng L
Cancer Epidemiol; 2016 Feb; 40():152-7. PubMed ID: 26724464
[TBL] [Abstract][Full Text] [Related]
3. Role of hedgehog signaling in ovarian cancer.
Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
[TBL] [Abstract][Full Text] [Related]
4. Activation of hedgehog signaling is not a frequent event in ovarian cancers.
Yang L; He J; Huang S; Zhang X; Bian Y; He N; Zhang H; Xie J
Mol Cancer; 2009 Nov; 8():112. PubMed ID: 19943941
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer.
Singh AN; Sharma N
Protein J; 2019 Oct; 38(5):537-550. PubMed ID: 30993446
[TBL] [Abstract][Full Text] [Related]
6. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer.
Xu FG; Ma QY; Wang Z
Cancer Lett; 2009 Oct; 283(2):119-24. PubMed ID: 19232458
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog signaling pathway: Epigenetic regulation and role in disease and cancer development.
Fattahi S; Pilehchian Langroudi M; Akhavan-Niaki H
J Cell Physiol; 2018 Aug; 233(8):5726-5735. PubMed ID: 29380372
[TBL] [Abstract][Full Text] [Related]
8. Proteins of the Hedgehog signaling pathway as therapeutic targets against cancer.
Nehmé R; Mus-Veteau I
Expert Rev Proteomics; 2010 Aug; 7(4):601-12. PubMed ID: 20653513
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog signaling pathway in ovarian cancer.
Szkandera J; Kiesslich T; Haybaeck J; Gerger A; Pichler M
Int J Mol Sci; 2013 Jan; 14(1):1179-96. PubMed ID: 23303278
[TBL] [Abstract][Full Text] [Related]
10. Targeting the hedgehog pathway: the development of cyclopamine and the development of anti-cancer drugs targeting the hedgehog pathway.
Gould A; Missailidis S
Mini Rev Med Chem; 2011 Mar; 11(3):200-13. PubMed ID: 21222574
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
[TBL] [Abstract][Full Text] [Related]
12. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
[TBL] [Abstract][Full Text] [Related]
13. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway.
Sekulic A; Mangold AR; Northfelt DW; LoRusso PM
Curr Opin Oncol; 2013 May; 25(3):218-23. PubMed ID: 23493193
[TBL] [Abstract][Full Text] [Related]
14. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
Yun JI; Kim HR; Park H; Kim SK; Lee J
Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
[TBL] [Abstract][Full Text] [Related]
16. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
17. Targeting the hedgehog pathway: role in cancer and clinical implications of its inhibition.
Cohen DJ
Hematol Oncol Clin North Am; 2012 Jun; 26(3):565-88, viii. PubMed ID: 22520980
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy.
Scales SJ; de Sauvage FJ
Trends Pharmacol Sci; 2009 Jun; 30(6):303-12. PubMed ID: 19443052
[TBL] [Abstract][Full Text] [Related]
19. The Hedgehog pathway as a drug target in cancer therapy.
Lauth M; Toftgård R
Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of the Hedgehog and Wnt pathways in cancer.
Wils LJ; Bijlsma MF
Crit Rev Oncol Hematol; 2018 Jan; 121():23-44. PubMed ID: 29279097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
